Logo
x

Search

Subscribe Now

Orphalan

Insights+: The US FDA New Drug Approvals in April 2022

Insights+: The US FDA New Drug Approvals in April 2022

  • May 19, 2022
Orphalan’s Cuvrior Receives the US FDA’s Approval for the Treatment of Adult Patients with Stable Wilson’s Disease

Orphalan’s Cuvrior Receives the US FDA’s Approval for the Treatment of Adult Patients with Stable Wilson’s Disease

  • May 2, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.